Yokoyama, Keitaro
257  Ergebnisse:
Personensuche X
?
 
?
3

Safety and effectiveness of ferric citrate hydrate in serum..:

Yokoyama, Keitaro ; Hashimoto, Teruo ; Okuda, Yuri...
Clinical and Experimental Nephrology.  26 (2022)  7 - p. 688-699 , 2022
 
?
5

MO519: Ferric Citrate Hydrate Improves Levels of Transferri..:

Yokoyama, Keitaro ; Inoue, Ryo ; Ito, Kyoko...
Nephrology Dialysis Transplantation.  37 (2022)  Supplement_3 - p. , 2022
 
?
6

Clinical feasibility of transfer to combined therapy with p..:

Maruyama, Yukio ; Yokoyama, Keitaro ; Higuchi, Chieko...
Therapeutic Apheresis and Dialysis.  26 (2022)  6 - p. 1226-1234 , 2022
 
?
8

Iron absorption and phosphate-lowering effects of ferric ci..:

Ito, Kyoko ; Yokoyama, Keitaro
International Urology and Nephrology.  55 (2022)  1 - p. 141-150 , 2022
 
?
9

MO525: Iron absorption and phosphate-lowering effects of fe..:

Ito, Kyoko ; Mitobe, Yuko ; Matsumoto, Yu.
Nephrology Dialysis Transplantation.  37 (2022)  Supplement_3 - p. , 2022
 
?
11

Relationship between serum calcium or phosphate levels and ..:

Asada, Shinji ; Yokoyama, Keitaro ; Miyakoshi, Chisato...
Clinical and Experimental Nephrology.  24 (2020)  7 - p. 630-637 , 2020
 
?
 
?
14

Comparison of peritoneal function within the first 1 year o..:

Asari, Kana ; Maruyama, Yukio ; Kishida, Kyoko...
Therapeutic Apheresis and Dialysis.  25 (2020)  3 - p. 314-322 , 2020
 
1-15